Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics
<p>Background: While a subgroup of patients with exacerbations of chronic obstructive pulmonary disease (COPD) clearly benefit from antibiotics, their identification remains challenging. We hypothesised that selective assessment of the balance between the two dominant bacterial groups (Gammap...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Published: |
Public Library of Science
2017
|
_version_ | 1826258957493075968 |
---|---|
author | Haldar, K Bafadhel, M Lau, K Berg, A Kwambana, B Kebadze, T Ramsheh, MY Barker, B Haldar, P Johnston, S Ketley, JM Brightling, CE Barer, MR |
author_facet | Haldar, K Bafadhel, M Lau, K Berg, A Kwambana, B Kebadze, T Ramsheh, MY Barker, B Haldar, P Johnston, S Ketley, JM Brightling, CE Barer, MR |
author_sort | Haldar, K |
collection | OXFORD |
description | <p>Background: While a subgroup of patients with exacerbations of chronic obstructive pulmonary disease (COPD) clearly benefit from antibiotics, their identification remains challenging. We hypothesised that selective assessment of the balance between the two dominant bacterial groups (Gammaproteobacteria (G) and Firmicutes (F)) in COPD sputum samples might reveal a subgroup with a bacterial community structure change at exacerbation that was restored to baseline on recovery and potentially reflects effective antibiotic treatment.</p><p> Methods: Phylogenetically specific 16S rRNA genes were determined by quantitative real time PCR to derive a G:F ratio in serial sputum samples from 66 extensively-phenotyped COPD exacerbation episodes.</p><p> Results: Cluster analysis based on Euclidean distance measures, generated across the 4 visit times (stable and exacerbation day: 0,14 and 42) for the 66 exacerbation episodes, revealed three subgroups designated HG, HF, and GF reflecting predominance or equivalence of the two target bacterial groups. While the other subgroups showed no change at exacerbation, the HG cluster (n = 20) was characterized by G:F ratios that increased significantly at exacerbation and returned to baseline on recovery (p<0.00001); ratios in the HG group also correlated positively with inflammatory markers and negatively with FEV1. At exacerbation G:F showed a significant receiver-operator-characteristic curve to identify the HG subgroup (AUC 0.90, p<0.0001).</p><p> Conclusions: The G:F ratio at exacerbation can be determined on a timescale compatible with decisions regarding clinical management. We propose that the G:F ratio has potential for use as a biomarker enabling selective use of antibiotics in COPD exacerbations and hence warrants further clinical evaluation.</p> |
first_indexed | 2024-03-06T18:42:16Z |
format | Journal article |
id | oxford-uuid:0d4c5bbe-bfa3-4f4b-8b1c-bca33aeda596 |
institution | University of Oxford |
last_indexed | 2024-03-06T18:42:16Z |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | dspace |
spelling | oxford-uuid:0d4c5bbe-bfa3-4f4b-8b1c-bca33aeda5962022-03-26T09:39:44ZMicrobiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibioticsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0d4c5bbe-bfa3-4f4b-8b1c-bca33aeda596Symplectic Elements at OxfordPublic Library of Science2017Haldar, KBafadhel, MLau, KBerg, AKwambana, BKebadze, TRamsheh, MYBarker, BHaldar, PJohnston, SKetley, JMBrightling, CEBarer, MR<p>Background: While a subgroup of patients with exacerbations of chronic obstructive pulmonary disease (COPD) clearly benefit from antibiotics, their identification remains challenging. We hypothesised that selective assessment of the balance between the two dominant bacterial groups (Gammaproteobacteria (G) and Firmicutes (F)) in COPD sputum samples might reveal a subgroup with a bacterial community structure change at exacerbation that was restored to baseline on recovery and potentially reflects effective antibiotic treatment.</p><p> Methods: Phylogenetically specific 16S rRNA genes were determined by quantitative real time PCR to derive a G:F ratio in serial sputum samples from 66 extensively-phenotyped COPD exacerbation episodes.</p><p> Results: Cluster analysis based on Euclidean distance measures, generated across the 4 visit times (stable and exacerbation day: 0,14 and 42) for the 66 exacerbation episodes, revealed three subgroups designated HG, HF, and GF reflecting predominance or equivalence of the two target bacterial groups. While the other subgroups showed no change at exacerbation, the HG cluster (n = 20) was characterized by G:F ratios that increased significantly at exacerbation and returned to baseline on recovery (p<0.00001); ratios in the HG group also correlated positively with inflammatory markers and negatively with FEV1. At exacerbation G:F showed a significant receiver-operator-characteristic curve to identify the HG subgroup (AUC 0.90, p<0.0001).</p><p> Conclusions: The G:F ratio at exacerbation can be determined on a timescale compatible with decisions regarding clinical management. We propose that the G:F ratio has potential for use as a biomarker enabling selective use of antibiotics in COPD exacerbations and hence warrants further clinical evaluation.</p> |
spellingShingle | Haldar, K Bafadhel, M Lau, K Berg, A Kwambana, B Kebadze, T Ramsheh, MY Barker, B Haldar, P Johnston, S Ketley, JM Brightling, CE Barer, MR Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics |
title | Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics |
title_full | Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics |
title_fullStr | Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics |
title_full_unstemmed | Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics |
title_short | Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics |
title_sort | microbiome balance in sputum determined by pcr stratifies copd exacerbations and shows potential for selective use of antibiotics |
work_keys_str_mv | AT haldark microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics AT bafadhelm microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics AT lauk microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics AT berga microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics AT kwambanab microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics AT kebadzet microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics AT ramshehmy microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics AT barkerb microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics AT haldarp microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics AT johnstons microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics AT ketleyjm microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics AT brightlingce microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics AT barermr microbiomebalanceinsputumdeterminedbypcrstratifiescopdexacerbationsandshowspotentialforselectiveuseofantibiotics |